SLN360
Silence Therapeutics
['illumina']
$a - - silence therapeutics presents new analysis from sln360 phase 1 single dose study in high lipoprotein(a) at the american heart association (aha) 2022 annual meeting
Building a platform where all investors are better informed and get smart about their investments. Please give a follow if you like what you see ??